P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results.

导出 OA

翻译打印收藏纠错

作者： Barbara,Petolicchio ^[1] ; Massimiliano,Toscano ^[2] ; Martina,Squitieri ^[2] ; Alessandro,Viganò ^[2] ; Edoardo,Vicenzini ^[2] ; Vittorio,Di Piero ^[2]

作者单位： Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy. barbara.petolicchio@gmail.com. ^[1] Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy. ^[2]

DOI 10.1186/1129-2377-16-S1-A112

PMID 28132276

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

The journal of headache and pain

2015年16卷Suppl 1期

A112页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results.

The journal of headache and pain

相似文献

The journal of headache and pain

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results.

The journal of headache and pain

相似文献

The journal of headache and pain

相关期刊

检索历史清除